Actively Recruiting
Motivational Interviews Post Hospitalisation on Maintaining AbstiNence for 1 Year après le Sevrage en Alcool
Led by University Hospital, Montpellier · Updated on 2026-02-05
104
Participants Needed
1
Research Sites
160 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this clinical study is to evaluate the efficacy of reinforced inpatient aftercare versus usual care on the percentage of days of abstinence during the first year following withdrawal in adults with alcohol use disorders undergoing inpatient withdrawal. The hypothesis is that reinforced post-withdrawal follow-up, of the motivational interview type, during the first 4 months following hospitalisation, in addition to the usual care, would allow : * Increase the percentage of days of abstinence in the year following withdrawal. * Reduce the rate of relapse in the year following withdrawal. * An increase in the cumulative and maximum duration of abstinence, an increase in motivation to maintain the change initiated and a reduction in the use of other substances in the year following withdrawal. * A reduction in the impact of risk factors involved in the relapse process in the year following withdrawal. All participants will have assessments to monitor their abstinence and consumption. In addition to their assessments, the experimental group will have motivational talks once every 15 days.
CONDITIONS
Official Title
Motivational Interviews Post Hospitalisation on Maintaining AbstiNence for 1 Year après le Sevrage en Alcool
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Alcohol use disorder defined by at least 2 DSM-V criteria for at least 12 months
- Currently being treated for alcohol withdrawal in hospital
- Have a goal of complete abstinence from alcohol
- Have access to a telephone for communication
You will not qualify if you...
- Lack of understanding of written and spoken French
- Failure to comply with addictology service rules or somatic complications of addiction leading to breach of withdrawal contract
- Discharge against medical advice or eviction during withdrawal hospitalisation
- Cognitive problems that impair understanding of the study and follow-up
- Serious decompensated somatic diseases
- Not enrolled in or not benefiting from a national health insurance scheme
- Legally protected persons under guardianship or curatorship
- Failure to provide signed informed consent
- Participation in another clinical trial at the same time
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Thomas RISDORFER DE ISSDENTZI
Montpellier, France, 3400
Actively Recruiting
Research Team
T
Thomas RISDORFER DE ISSDENTZI
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here